Literature DB >> 12150847

Occult hepatitis B.

Michael Torbenson1, David L Thomas.   

Abstract

Worldwide, chronic hepatitis B virus (HBV) infection is the primary cause of cirrhosis and hepatocellular carcinoma and is one of the ten leading causes of death. Traditionally, people with chronic HBV infection have been identified with blood tests for HBV antigens and antibodies. Recently, another group of patients with chronic HBV infection has been identified by sensitive, molecular testing for HBV DNA. Members of this group are often referred to as having occult hepatitis B because they are HBV-DNA positive, but hepatitis B surface antigen negative. Occult hepatitis B occurs in a number of clinical settings. In this review, we examine occult hepatitis B in people co-infected with hepatitis C, in whom occult hepatitis B has been associated with advanced fibrosis and diminished response to interferon alpha. Although much more research is needed, existing reports justify a heightened awareness of the medical importance and means of testing for occult hepatitis B.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150847     DOI: 10.1016/s1473-3099(02)00345-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  149 in total

1.  Effects of autoantibodies against beta(1)-adrenoceptor in hepatitis virus myocarditis on action potential and L-type Ca(2+) currents.

Authors:  Kun Liu; Yu-Hua Liao; Zhao-Hui Wang; Shu-Li Li; Ming Wang; Ling-Lan Zeng; Ming Tang
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

2.  Occult hepatitis B in blood donors: a description of two cases.

Authors:  Ciro Capezzuto; Eva Franchi; Simona Urbani; Luisa Romanò; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-10       Impact factor: 3.443

Review 3.  Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.

Authors:  Angelica Maldonado-Rodriguez; Ana Maria Cevallos; Othon Rojas-Montes; Karina Enriquez-Navarro; Ma Teresa Alvarez-Muñoz; Rosalia Lira
Journal:  World J Hepatol       Date:  2015-02-27

4.  Is hepatitis C virus positivity a contributing factor to occult hepatitis B virus infection in hemodialysis patients?

Authors:  Mehmet Kanbay; Gurden Gur; Ali Akcay; Haldun Selcuk; Ugur Yilmaz; Hande Arslan; Sedat Boyacioglu; Fatma Nurhan Ozdemir
Journal:  Dig Dis Sci       Date:  2006-09-15       Impact factor: 3.199

Review 5.  Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies.

Authors:  L H Calabrese; N N Zein; D Vassilopoulos
Journal:  Ann Rheum Dis       Date:  2006-04-20       Impact factor: 19.103

6.  Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.

Authors:  Judith I Tsui; Audrey L French; Eric C Seaberg; Michael Augenbraun; Marek Nowicki; Marion Peters; Phyllis C Tien
Journal:  Clin Infect Dis       Date:  2007-08-10       Impact factor: 9.079

7.  Development of occult hepatitis B viral infection in pregnancy: implications for antenatal screening in women from endemic areas.

Authors:  Philip Chang; Jeffrey Tu; Antony Chesterman; Robert Kim; Peter Robertson; William D Rawlinson; Stephen M Riordan
Journal:  Obstet Med       Date:  2010-09-17

8.  Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination.

Authors:  Qing-Qing Yao; Xiao-Lian Dong; Xue-Cai Wang; Sheng-Xiang Ge; An-Qun Hu; Hai-Yan Liu; Yueping Alex Wang; Quan Yuan; Ying-Jie Zheng
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

9.  Testing for hepatitis B infection in prospective chemotherapy patients: a retrospective study.

Authors:  Ying Wang; Xin-Mei Luo; Dan Yang; Jie Zhang; Hong-Yu Zhuo; Jian Zhang; Yu Jiang
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

10.  Limited infection with occult hepatitis B virus in drug users in the USA.

Authors:  Jason T Blackard; Christina M Martin; Satarupa Sengupta; Janet Forrester
Journal:  Hepatol Res       Date:  2012-08-22       Impact factor: 4.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.